[1]
“Comparison of the efficacy and safety of bimatoprost (0.03 %) and travoprost (0.004 %) in patients with primary open angle glaucoma”, Nep J Oph, vol. 5, no. 1, pp. 75–80, Mar. 2013, doi: 10.3126/nepjoph.v5i1.7831.